Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica

West Indian Medical Journal

Volumn 57, Issue 3, 2008, Pages 231-237

  White, Y R G ^a   Pierre, R B ^a,b   Steel Duncan, J ^a   Palmer, P ^a   Evans Gilbert, T ^c   Moore, J ^a   Rodriguez, B ^d   Christie, Celia D C ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^c Bustamante Hospital for Children   (Jamaica)

^d Department of Paediatric Medicine   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CAREGIVER; CD4 LYMPHOCYTE COUNT; CHILD; CHILD CARE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIRECTLY OBSERVED THERAPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; JAMAICA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PEDIATRIC HOSPITAL; PSYCHOLOGICAL ASPECT; RESIDENTIAL CARE; SOCIAL ASPECT; TREATMENT DURATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; JAMAICA; LAMIVUDINE; MALE; MEDICATION ADHERENCE; NEVIRAPINE; QUESTIONNAIRES; YOUNG ADULT; ZIDOVUDINE;

EID: 55749092422     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Figueroa JP, An overview of HIV/AIDS in Jamaica: Strengthening the response. West Indian Med J 2004; 53: 277-82.
2. Christie CDC. A pediatric and perinatal HIV/AIDS leadership initiative in Kingston, Jamaica. West Indian Med J 2004; 53: 283-92.
3. Rodriquez B, Steel-Duncan JC, Pierre R, Evans-Gilbert T, Hambleton I, Palmer P et al. Socio-demographic characteristics of HIV-exposed and HIV-infected Jamaican children. West Indian Med J 2004; 53: 303-7.
4. World Health Organization. Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond, March 2006. [monograph on the internet]. Geneva: WHO Press; 2006 [cited 2007 September 6]. Available from: http://www.who.int/hiv/ progreport2006_en.pdf.
5. Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriquez B, Whorms S, Hambleton I et al. Antiretroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 2004; 53: 322-6.
6. Watson D, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Paediatr Infect Dis J 1999; 18: 682-9.
7. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004; 23: 1035-41.
8. Reddington C, Cohen J, Baldillo A, Toye M, Smith D, Kneut C et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J 2000; 19: 1148-53.
9. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H, Paediatric, European Network for Treatment of AIDS Steering Committee. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Paediatr Infect Dis J 2003; 22: 56-62.
10. King JR, Acosta EP, Chadwick E, Yogev R, Crain M, Pass R et al. Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J 2003; 22: 239-44.
11. American Public Health Association (APHA). Adherence to HIV treatment regimens: recommendations for best practices [monograph on the internet]. 2004 [cited 2007 September 9]. Available from: http://www.apha.org/NR/rdonlyres/A030DDB1-02C8-4D80-923B-7EF6608D62F1/ 0/BestPracticesnew.pdf.
12. Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K et al. Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 2002; 109: e61.
13. Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr 2003; 33: 211-8.
14. Byrne M, Honig J, Jurgrau A, Hefferman SM, Donahue MC. Achieving adherence with antiretroviral medications for pediatric HIV disease. AIDS Read 2002; 12: 151-4, 161-4.
15. Dolezal C, Mellins C, Brackis-Cott E, Abrams EJ. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol 2003; 28: 355-361.
16. Steel RG, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev 2003; 6: 17-30.
17. Goode M, McMaugh A, Crisp J, Wales S, Ziegler JB. Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care 2003; 15: 403-8.
18. Brackis-Cott E, Mellins CA, Abrams E, Reval T, Dolezal C. Pediatric HIV medication: the views of medical providers from two primary care programs. J Paediatr Health Care 2003; 17: 252-60.
19. Pierre R, Steel-Duncan JC, Evans-Gilbert T, Rodriquez B, Palmer P, Smikle MF et al. CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS. West Indian Med J 2004; 53: 315-21.
20. Centers for Disease Control (CDC). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 1987; 36 Suppl 1: 1S-15S.
21. Okatcha K. Community involvement in integrated day care centres for young children affected by HIV/AIDS: a case study from western Kenya. August 2006 [Abstract no. THPE0834]. XVI International AIDS Conference, Toronto, Canada.
22. Ellis DA, Naar-King S, Cunningham PB, Secord E. Use of multisystem therapy to improve antiretroviral adherence and health outcomes in HIV-infected paediatric patients: evaluation of a pilot programme. AIDS Patient Care STDS 2006; 20: 112-121.
23. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics 2007; 119: e1371-83. Epub 2007 May 28.
24. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12: 1198-202.
25. Ssewanyana I, Elrefaei M, Dorsey G, Ruel T, Jones NG, Gasasira A et al. Profile of T cell immune responses in HIV-infected children from Uganda. J Infect Dis 2007; 196: 1667-70. Epub 2007 Oct 25.